Literature DB >> 22114995

Long-term maternal morbidity associated with repeat cesarean delivery.

Erin A S Clark1, Robert M Silver.   

Abstract

Concern regarding the association between cesarean delivery and long-term maternal morbidity is growing as the rate of cesarean delivery continues to increase. Observational evidence suggests that the risk of morbidity increases with increasing number of cesarean deliveries. The dominant maternal risk in subsequent pregnancies is placenta accreta spectrum disorder and its associated complications. A history of multiple cesarean deliveries is the major risk factor for this condition. Pregnancies following cesarean delivery also have increased risk for other types of abnormal placentation, reduced fetal growth, preterm birth, and possibly stillbirth. Chronic maternal morbidities associated with cesarean delivery include pelvic pain and adhesions. Adverse reproductive effects may include decreased fertility and increased risk of spontaneous abortion and ectopic pregnancy. Clinicians and patients need to be aware of the long-term risks associated with cesarean delivery so that they can be considered when determining the method of delivery for first and subsequent births.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22114995     DOI: 10.1016/j.ajog.2011.09.028

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  40 in total

1.  Complications and outcomes of repeat cesarean section in adolescent women.

Authors:  Mustafa Kaplanoglu; Atilla Karateke; Burak Un; Utku Akgor; Ali Baloğlu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Attitudes and practices regarding late preterm birth among American obstetrician-gynecologists.

Authors:  Michael L Power; Zsakeba Henderson; Julia E Behler; Jay Schulkin
Journal:  J Womens Health (Larchmt)       Date:  2013-01-25       Impact factor: 2.681

3.  Effectiveness and short-term safety of modified sodium hyaluronic acid-carboxymethylcellulose at cesarean delivery: a randomized trial.

Authors:  Daniel G Kiefer; Jolene C Muscat; Jarrett Santorelli; Martin R Chavez; Cande V Ananth; John C Smulian; Anthony M Vintzileos
Journal:  Am J Obstet Gynecol       Date:  2015-10-23       Impact factor: 8.661

4.  Optimal Timing of Delivery in Women with Higher Order Cesareans: A Cohort Study.

Authors:  Emily S Miller; Chloe Nielsen; Kelly B Zafman; Nathan S Fox
Journal:  Am J Perinatol       Date:  2018-04-16       Impact factor: 1.862

5.  Two practice models in one labor and delivery unit: association with cesarean delivery rates.

Authors:  Malini Anand Nijagal; Miriam Kuppermann; Sanae Nakagawa; Yvonne Cheng
Journal:  Am J Obstet Gynecol       Date:  2014-11-13       Impact factor: 8.661

6.  Comparison of Primary Cesarean Delivery Rates Among Low-Risk Women in Urban and Rural Hospitals in Hawaii.

Authors:  Ann Lee Chang; Misty Pacheco; Kurt Yoshino; Jill Miyamura; Jay Maddock
Journal:  Matern Child Health J       Date:  2016-09

7.  Anesthesia for in utero repair of myelomeningocele.

Authors:  Marla Ferschl; Robert Ball; Hanmin Lee; Mark D Rollins
Journal:  Anesthesiology       Date:  2013-05       Impact factor: 7.892

8.  Association between provider type and cesarean birth in healthy nulliparous laboring women: A retrospective cohort study.

Authors:  Nicole S Carlson; Elizabeth J Corwin; Teri L Hernandez; Elizabeth Holt; Nancy K Lowe; K Joseph Hurt
Journal:  Birth       Date:  2018-01-31       Impact factor: 3.689

9.  Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean Delivery: The PROCEED Randomized Clinical Trial.

Authors:  Miriam Kuppermann; Anjali J Kaimal; Cinthia Blat; Juan Gonzalez; Mari-Paule Thiet; Yamilee Bermingham; Anna L Altshuler; Allison S Bryant; Peter Bacchetti; William A Grobman
Journal:  JAMA       Date:  2020-06-02       Impact factor: 56.272

10.  New medical risks affecting obstetrics after implementation of the two-child policy in China.

Authors:  Qiang Li; Dongrui Deng
Journal:  Front Med       Date:  2017-09-30       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.